121 related articles for article (PubMed ID: 17073742)
1. Negative regulation of leucocyte functions by CD33-related siglecs.
Avril T; Attrill H; Zhang J; Raper A; Crocker PR
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1024-7. PubMed ID: 17073742
[TBL] [Abstract][Full Text] [Related]
2. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.
Murch SH
Med Hypotheses; 2020 Nov; 144():110168. PubMed ID: 33254494
[TBL] [Abstract][Full Text] [Related]
3. Viewing Siglecs through the lens of tumor immunology.
Fraschilla I; Pillai S
Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
[TBL] [Abstract][Full Text] [Related]
4. Siglecs as targets for therapy in immune-cell-mediated disease.
O'Reilly MK; Paulson JC
Trends Pharmacol Sci; 2009 May; 30(5):240-8. PubMed ID: 19359050
[TBL] [Abstract][Full Text] [Related]
5. Targeting Siglec-Sialylated MUC1 Immune Axis in Cancer.
Ayyalasomayajula R; Cudic M
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611013
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases.
Wißfeld J; Abou Assale T; Cuevas-Rios G; Liao H; Neumann H
Front Neurol; 2024; 15():1330874. PubMed ID: 38529039
[TBL] [Abstract][Full Text] [Related]
7. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing.
Malik M; Simpson JF; Parikh I; Wilfred BR; Fardo DW; Nelson PT; Estus S
J Neurosci; 2013 Aug; 33(33):13320-5. PubMed ID: 23946390
[TBL] [Abstract][Full Text] [Related]
8. CD33-related siglecs as potential modulators of inflammatory responses.
Crocker PR; McMillan SJ; Richards HE
Ann N Y Acad Sci; 2012 Apr; 1253():102-11. PubMed ID: 22352893
[TBL] [Abstract][Full Text] [Related]
9. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
Cao H; Crocker PR
Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
[TBL] [Abstract][Full Text] [Related]
10. Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis.
Liu C; Zhu J; Mi Y; Jin T
J Neuroinflammation; 2022 Dec; 19(1):298. PubMed ID: 36510261
[TBL] [Abstract][Full Text] [Related]
11. α2-3 Sialic acid binding and uptake by human monocyte-derived dendritic cells alters metabolism and cytokine release and initiates tolerizing T cell programming.
Lübbers J; Eveline Li RJ; Gorki FS; Bruijns SCM; Gallagher A; Kalay H; Ambrosini M; Molenaar D; Van den Bossche J; van Vliet SJ; van Kooyk Y
Immunother Adv; 2021 Jan; 1(1):ltab012. PubMed ID: 35919745
[TBL] [Abstract][Full Text] [Related]
12.
Yang J; Ma W; Wu Y; Zhou H; Song S; Cao Y; Wang C; Liu X; Ren J; Duan J; Pei Z; Jin C
Microbiol Spectr; 2021 Dec; 9(3):e0039921. PubMed ID: 34878295
[TBL] [Abstract][Full Text] [Related]
13. Siglecs Modulate Activities of Immune Cells Through Positive and Negative Regulation of ROS Generation.
Karmakar J; Mukherjee K; Mandal C
Front Immunol; 2021; 12():758588. PubMed ID: 34804046
[TBL] [Abstract][Full Text] [Related]
14. Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape.
Jarahian M; Marofi F; Maashi MS; Ghaebi M; Khezri A; Berger MR
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680351
[TBL] [Abstract][Full Text] [Related]
15. Activating Natural Killer Cell Receptors, Selectins, and Inhibitory Siglecs Recognize Ebolavirus Glycoprotein.
Jarahian M; Marstaller K; Banna N; Ahani R; Etemadzadeh MH; Boller LK; Azadmanesh K; Cid-Arregui A; Khezri A; Berger MR; Momburg F; Watzl C
J Innate Immun; 2022; 14(2):135-147. PubMed ID: 34425576
[TBL] [Abstract][Full Text] [Related]
16. Sialic Acids and Their Influence on Human NK Cell Function.
Rosenstock P; Kaufmann T
Cells; 2021 Jan; 10(2):. PubMed ID: 33572710
[TBL] [Abstract][Full Text] [Related]
17. Sialic acid metabolism as a potential therapeutic target of atherosclerosis.
Zhang C; Chen J; Liu Y; Xu D
Lipids Health Dis; 2019 Sep; 18(1):173. PubMed ID: 31521172
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions.
Lübbers J; Rodríguez E; van Kooyk Y
Front Immunol; 2018; 9():2807. PubMed ID: 30581432
[TBL] [Abstract][Full Text] [Related]
19. Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients.
Carvalheiro T; Horta S; van Roon JAG; Santiago M; Salvador MJ; Trindade H; Radstake TRDJ; da Silva JAP; Paiva A
Inflamm Res; 2018 Feb; 67(2):169-177. PubMed ID: 29127442
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
